ENTOD PHARMACEUTICALS LIMITED
Location
Maharashtra
Founded
1981-10-31
Website
Risk Signals
49 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Industrial Organic Chemicals, Not Elsewhere Classified, Special Industry Machinery, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ENTOD PHARMACEUTICALS LIMITED
Live alerts from global media, monitored by Business Radar
2024-01-31 (indiatimes.com)
Entod Pharmaceuticals inaugurates R&D centre in Navi Mumbai - ET HealthWorld | Pharma
Entod Pharmaceuticals: The facility will focus on developing next-generation molecules using generative artificial intelligence (AI) platforms, particularly in the ophthalmic, ENT, paediatric, and skin care segments. Some of these molecules are expected to be indigenous to India.
Read more
2023-01-30 (healthcareradius.in)
Entod unveils R&D facility in Navi Mumbai -
It is approved by the Department of Scientific and Industrial Research (DSIR). Entod unveils R&D facility in Navi Mumbai. Department of Scientific and Industrial Research, Formulation and molecular research, New product development, R&D facility. Clinical.
Read more
2021-08-12 (expresspharma.in)
India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug modules
Inefficient clinical research, low productivity, low learning and study curve, lack of facilities and trained investigators, etc. have stalled the discovery of new drug molecules, reveals Nikkhil K Masurkar, Executive Director, ENTOD Pharmaceuticals to Express Pharma, in an exclusive interaction,
Read more
(biospectrumindia.com)
Entod Pharma unveils new R&D facility in Mumbai
Designed with state-of-the-art equipment and the latest analytical & formulation research tools
Read more